Jeroen Ouwehand, Clifford Chance senior partner
Ex-Kleiner Perkins, Amgen execs seal $500m double fundraise targeting transformative life science companies
Carlyle secondaries arm raises over $10bn across new flagship fund, co-investment vehicles